Injectable Egg-Free Influenza Vaccine
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2DP-24-R-0006
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
-
- Yu Chen yu.chen@dla.mil (445) 737-7606
Notice details come from SAM.gov. Updated .
About this opportunity
Paragraph 1:
The Defense Logistics Agency Troop Support is seeking to procure an Injectable Egg-Free Influenza Vaccine for the 2025-2026 flu season. The vaccine must be FDA-approved for immunizing individuals 18 years and older, with the formula to be determined by the FDA's Vaccines and Related Biological Products Advisory Committee. The planned contract is a requirements contract for an estimated annual quantity of approximately 280,000 doses, with a maximum quantity of 150% of the annual estimate. Successful contractors must have FDA approval and the vaccine must be ACIP recommended. The solicitation is expected to be issued on or around September 9, 2024.
Paragraph 2:
This procurement does not have a set-aside designation. The anticipated delivery schedule requires the contractor to deliver 40% of the order quantity by August 11, 2025, 25% by August 25, 2025, 25% by September 8, 2025, and the remaining 10% by September 22, 2025. There is no guaranteed minimum quantity, and the ordered quantities shall be delivered to the Defense Depot New Cumberland, PA.
Notice text
2 versions
Update #2 · Latest ·
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Egg-Free Influenza Vaccine for the 2025-2026 flu season. Approximately 280,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.)The vaccines shall be in the following presentations: prefilled syringes. The vaccine shall be FDA-approved for immunizing individuals 18 years and older.
The formula for the 2025-2026 season shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award.
An indefinite quantity contract is proposed. The quantity indicated is anannual estimate only. The guaranteed minimum will be 10% of the annual estimate, and a contract maximum will be established at 150% of theannual estimate.
Ordered quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the order qty. by August 11, 2025, 25% by August 25, 2025, 25% by September 8, 2025, and the residual 10% by September 22, 2025 after receipt of the delivery order. The Delivery Schedule shall apply to the estimated annual quantity. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
Solicitation SPE2DP-24-R-0006 is expected to be issued on or around October 18, 2024 and can be found on the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov.
Update #1 ·
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Egg-Free Influenza Vaccine for the 2025-2026 flu season. The vaccines shall be in the following presentations: prefilled syringes. The vaccine shall be FDA-approved for immunizing individuals 18 years and older.
The formula for the 2025-2026 season shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award.
The type of contract planned is a requirements contract (see FAR 16.503) for an estimated annual quantity of approximately 280,000 doses. The quantities indicated are annual estimates only and may increase or decrease pending receipt of final Service requirements. There is no guaranteed minimum quantity. The annual maximum quantity will be set at 150% of the annual estimated quantity.
Ordered quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the order qty. by August 11, 2025, 25% by August 25, 2025, 25% by September 8, 2025, and the residual 10% by September 22, 2025 after receipt of the delivery order. The Delivery Schedule shall apply to the estimated annual quantity. This delivery schedule is the preferred delivery schedule. Other delivery schedules may be considered.
Solicitation SPE2DP-24-R-0006 is expected to be issued on or around September 9, 2024 and can be found on the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Injectable Egg-Free Influenza Vaccine | Award Notice | |
| Injectable Egg-Free Influenza Vaccine | Solicitation | |
| Injectable Egg-Free Influenza Vaccine | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity